# Yeasen Biotechnology (Shanghai) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yeasen-biotechnology-shanghai-co

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.yeasen.com
- Total disclosed funding: $94M
- Latest round: Series B (Aug 26, 2021)
- Investors on record: 6

## About

Established in 2014 and based in Shanghai, China, Yeasen Biotechnology (Shanghai) Co., Ltd. is a company that engages in the research and development, production of tool enzyme raw materials and antigen antibodies. The company has branches in Beijing, Nanjing, Guangzhou and other places. It has established Yeasen Biotechnology Research Institute, Yeasen Biological R&D Center and Ultra Clean Factory for Molecular Enzyme.

The company's products include molecular enzyme raw materials, basic biological reagent, sequencing kits, molecular diagnostic testing kits, etc.

## Funding rounds

- Series B, Aug 26, 2021, $46M — CPE Funds Management, HM Capital, Zhangjiang Torch Investment, Huasai Zhikang
- Series B, Jun 15, 2021, $39M — Legend Capital, Step Venture Capital
- Series A, Jul 10, 2020, $8.6M — Step Venture Capital

## Investors

- Step Venture Capital (https://capitalatlas.ai/funds/step-venture-capital) — Series A, Series B
- Legend Capital — Series B
- CPE Funds Management (https://capitalatlas.ai/funds/cpe-funds-management) — Series B
- HM Capital (https://capitalatlas.ai/funds/hm-capital) — Series B
- Zhangjiang Torch Investment (https://capitalatlas.ai/funds/zhangjiang-torch-investment) — Series B
- Huasai Zhikang — Series B